Clearmind Medicine, a biotech firm known for its work in neurodegenerative disease, is expanding into the electric‑vehicle (EV) sector by acquiring a majority stake in Charging Robotics, a startup that develops wireless charging technology for EVs. The deal positions Clearmind to diversify its portfolio and tap into the rapidly growing EV infrastructure market, while providing Charging Robotics with capital and strategic support to accelerate product commercialization. Industry observers note that the partnership could accelerate the deployment of contactless charging stations, potentially reducing installation costs and improving convenience for EV owners. The acquisition reflects a broader trend of cross‑industry collaborations aimed at integrating advanced technologies into sustainable transportation solutions.
Clearmind Medicine to Acquire Majority Stake in Charging Robotics for Wireless EV Charging Solutions Quiver Quantitative
